Given that SRp55 is commonly mutated in breast and colorectal cancers [52], and influences the alternative splicing patterns of several tumor-associated genes like KIT, CD44, and FGFR1 [53], it is not surprising that SRp55 depletion decreased the invasion of breast cancer cells. Here, CD44 is linked to breast carcinoma.